Agios to Webcast Conference Call of Fourth Quarter and Year End 2020 Financial Results on February 25, 2021
February 11 2021 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat cancer and genetically defined
diseases, today announced that the company will host a conference
call and live webcast on Thursday, February 25, 2021 at 8:00 a.m.
ET to report its fourth quarter and year end 2020 financial results
and other business highlights.
A live webcast can be accessed under "Events &
Presentations" in the Investors section of the company's website at
www.agios.com. The conference call can be accessed by dialing
1-877-377-7098 (domestic) or 1-631-291-4547 (international) and
referring to conference ID 8442238. The webcast will be archived
and made available for replay on the company's website beginning
approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat malignant
hematology, solid tumors and genetically defined diseases through
scientific leadership in the field of cellular metabolism. In
addition to an active research and discovery pipeline across these
three therapeutic areas, Agios has two approved oncology precision
medicines and multiple first-in-class investigational therapies in
clinical and/or preclinical development. For more information,
please visit the company's website at www.agios.com.
Contacts
Investors:Holly Manning, 617-844-6630Director,
Investor RelationsHolly.Manning@agios.com
Media:Jessica Rennekamp, 857-209-3286Associate
Director, Corporate
CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024